Cargando…

Resibufogenin inhibits the malignant characteristics of multiple myeloma cells by blocking the PI3K/Akt signaling pathway

Resibufogenin (RBG) is an active ingredient of toad venom that also has antitumor potential. The present study aimed to investigate the role of RBG in multiple myeloma (MM) and the underlying action mechanism involving the PI3K/Akt signaling pathway. A human MM cell line, RPMI8226, was treated with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Yan, Hong, Zirui, Jin, Keting, Lin, Chenjun, Xiang, Jingjing, Ge, Hangping, Zheng, Zhiyin, Shen, Jianping, Deng, Shu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2022
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9185807/ https://www.ncbi.nlm.nih.gov/pubmed/35720619 http://dx.doi.org/10.3892/etm.2022.11368

Ejemplares similares

Resibufogenin Suppresses Triple-Negative Breast Cancer Angiogenesis by Blocking VEGFR2-Mediated Signaling Pathway
por: Yang, Ting, et al.
Publicado: (2021)

Resibufogenin and Cinobufagin Activate Central Neurons through an Ouabain-Like Action
por: Wang, Ze-Jun, et al.
Publicado: (2014)

Resibufogenin Induces G1-Phase Arrest through the Proteasomal Degradation of Cyclin D1 in Human Malignant Tumor Cells
por: Ichikawa, Masami, et al.
Publicado: (2015)

Curcumin in Combination With Omacetaxine Suppress Lymphoma Cell Growth, Migration, Invasion, and Angiogenesis via Inhibition of VEGF/Akt Signaling Pathway
por: Zhang, Yu, et al.
Publicado: (2021)

Resibufogenin suppresses colorectal cancer growth and metastasis through RIP3-mediated necroptosis
por: Han, Qinrui, et al.
Publicado: (2018)

Coexistence of thrombotic thrombocytopenic purpura and immune thrombocytopenic purpura in an Asian woman: a case report
por: Ge, Hangping, et al.
Publicado: (2022)

Anti-Myeloma Activity of Akt Inhibition Is Linked to the Activation Status of PI3K/Akt and MEK/ERK Pathway
por: Ramakrishnan, Vijay, et al.
Publicado: (2012)

Research progress on the PI3K/AKT signaling pathway in gynecological cancer
por: Shi, Xiang, et al.
Publicado: (2019)

Role of PI3K/AKT pathway in cancer: the framework of malignant behavior
por: Jiang, Ningni, et al.
Publicado: (2020)

Promising galactose-decorated biodegradable poloxamer 188-PLGA diblock copolymer nanoparticles of resibufogenin for enhancing liver cancer therapy
por: Dong, Hao, et al.
Publicado: (2017)

TRIM14 regulates melanoma malignancy via PTEN/PI3K/AKT and STAT3 pathways
por: Chen, Jiangyan, et al.
Publicado: (2021)

Enhancement of Dissolving Capacity and Reducing Gastric Mucosa Irritation by Complex Formation of Resibufogenin with β-Cyclodextrin or 2-Hydroxypropyl-β-cyclodextrin
por: Liu, Nan, et al.
Publicado: (2022)

PAK4 confers the malignance of cervical cancers and contributes to the cisplatin-resistance in cervical cancer cells via PI3K/AKT pathway
por: Shu, Xiang-Rong, et al.
Publicado: (2015)

Anlotinib suppresses tumor progression via blocking the VEGFR2/PI3K/AKT cascade in intrahepatic cholangiocarcinoma
por: Song, Fei, et al.
Publicado: (2020)

β-Escin inhibits the proliferation of osteosarcoma cells via blocking the PI3K/Akt pathway
por: Zhu, Minyu, et al.
Publicado: (2018)

Inhibiting PI3K–AKT–mTOR Signaling in Multiple Myeloma-Associated Mesenchymal Stem Cells Impedes the Proliferation of Multiple Myeloma Cells
por: Heinemann, Luca, et al.
Publicado: (2022)

Resibufogenin Targets the ATP1A1 Signaling Cascade to Induce G2/M Phase Arrest and Inhibit Invasion in Glioma
por: Zhang, Xun, et al.
Publicado: (2022)

Liver-targeting Resibufogenin-loaded poly(lactic-co-glycolic acid)-d-α-tocopheryl polyethylene glycol 1000 succinate nanoparticles for liver cancer therapy
por: Chu, Qiuchen, et al.
Publicado: (2016)

NAT10 acetylates BCL-XL mRNA to promote the proliferation of multiple myeloma cells through PI3K-AKT pathway
por: Zhang, Yuanjiao, et al.
Publicado: (2022)

SETDB1 induces lenalidomide resistance in multiple myeloma cells via epithelial‑mesenchymal transition and PI3K/AKT pathway activation
por: Qian, Xiaoli, et al.
Publicado: (2023)

The Antagonistic Effect of Glutamine on Zearalenone-Induced Apoptosis via PI3K/Akt Signaling Pathway in IPEC-J2 Cells
por: Wang, Tianhu, et al.
Publicado: (2021)

Effect of Eriodictyol on Retinoblastoma via the PI3K/Akt Pathway
por: Wen, Shu, et al.
Publicado: (2021)

The role of the PI3K/AKT signalling pathway in the corneal epithelium: recent updates
por: Chen, Kuangqi, et al.
Publicado: (2022)

PI3K/Akt signaling transduction pathway, erythropoiesis and glycolysis in hypoxia
por: Xie, Youbang, et al.
Publicado: (2019)

The Translational Landscape Revealed the Sequential Treatment Containing ATRA plus PI3K/AKT Inhibitors as an Efficient Strategy for AML Therapy
por: Wang, Ke, et al.
Publicado: (2022)

Curcumin in combination with homoharringtonine suppresses lymphoma cell growth by inhibiting the TGF-β/Smad3 signaling pathway
por: Zhang, Yu, et al.
Publicado: (2021)

Correction for: Curcumin in combination with homoharringtonine suppresses lymphoma cell growth by inhibiting the TGF-β/Smad3 signaling pathway
por: Zhang, Yu, et al.
Publicado: (2022)

The Combination of Jiedu Xiaoluo Decoction with Autologous Peripheral Blood Stem Cell Transplantation (APBSCT) Accelerates Disease Remission of Non-Hodgkin Lymphoma
por: Zhang, Yu, et al.
Publicado: (2021)

Blocks to thyroid cancer cell apoptosis can be overcome by inhibition of the MAPK and PI3K/AKT pathways
por: Gunda, V, et al.
Publicado: (2014)

Blocking the PI3K/AKT pathway enhances mammalian reovirus replication by repressing IFN-stimulated genes
por: Tian, Jin, et al.
Publicado: (2015)

Inhibition of BUB1 suppresses tumorigenesis of osteosarcoma via blocking of PI3K/Akt and ERK pathways
por: Huang, Zhen, et al.
Publicado: (2021)

Upregulation of SIRT1 by Evodiamine activates PI3K/AKT pathway and blocks intervertebral disc degeneration
por: Kuai, Jianbo, et al.
Publicado: (2022)

PI3K/Akt/mTOR Signaling Pathway in Blood Malignancies—New Therapeutic Possibilities
por: Wiese, Wojciech, et al.
Publicado: (2023)

The PI3K/AKT signaling pathway regulates ABCG2 expression and confers resistance to chemotherapy in human multiple myeloma
por: Wang, Lei, et al.
Publicado: (2019)

Control of the PI3K/Akt pathway by porcine reproductive and respiratory syndrome virus
por: Zhu, Liqian, et al.
Publicado: (2013)

Reduced m6A modification predicts malignant phenotypes and augmented Wnt/PI3K‐Akt signaling in gastric cancer
por: Zhang, Cheng, et al.
Publicado: (2019)

miR-3651 Participates in the Growth Cycle of Hepatocellular Carcinoma Cells and Promotes the Malignant Metastasis via the PI3K/AKT/mTOR Signalling Pathway
por: Liu, Yawei, et al.
Publicado: (2022)

Getting the Akt Together: Guiding Intracellular Akt Activity by PI3K
por: Yudushkin, Ivan
Publicado: (2019)

HijAkt: The PI3K/Akt Pathway in Virus Replication and Pathogenesis
por: Dunn, Ewan F., et al.
Publicado: (2012)

PI3K/AKT Pathway and Brain Malformations
por: Rice, Gavin B., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_upbe5kd6465k3v06stf6dj06le